| 我国结核病免疫学预防、治疗与诊断用制品发展进程与展望 |
| |
| 引用本文： | 赵爱华,王国治,徐苗.我国结核病免疫学预防、治疗与诊断用制品发展进程与展望[J].中国防痨通讯,2019,41(11):1149-1154. |
| |
| 作者姓名： | 赵爱华 王国治 徐苗 |
| |
| 作者单位： | 102629.北京,中国食品药品检定研究院结核病疫苗室 |
| |
| 摘 要： | 结核病的免疫学预防、治疗与诊断是控制结核病的最重要措施之一。作者总结了我国结核病免疫学生物制品的发展进程、研究现状及未来的发展方向,同时展望了在已构建的结核病免疫预防体系框架下,有机运用各种生物制品,降低我国结核感染率、发病率,改变我国结核病高负担现状的可能性。
|
| 关 键 词： | 结核 免疫学技术 预防和防护用药 诊断 治疗应用 |
| 收稿时间： | 2019-09-04 |
Retrospect and prospect on biological products for immunological prevention,therapy and diagnosis of tuberculosis in China |
| |
| ZHAO Ai-hua,WANG Guo-zhi,XU Miao.Retrospect and prospect on biological products for immunological prevention,therapy and diagnosis of tuberculosis in China[J].The Journal of The Chinese Antituberculosis Association,2019,41(11):1149-1154. |
| |
| Authors: | ZHAO Ai-hua WANG Guo-zhi XU Miao |
| |
| Institution: | Division of Tuberculosis Vaccines, National Institutes for Food and Drug Control, Beijing 102629, China |
| |
| Abstract: | Immunological prevention, treatment and diagnosis of tuberculosis is one of the most necessary measures to control tuberculosis. This paper summarizes the development, research status and future development direction of tuberculosis-related biological products in China, and then prospects the organic use of various biological products under the framework of the established tuberculosis immune prevention system to reduce the rate of tuberculosis infection and incidence, as well as the possibility of changing the status quo of high burden of tuberculosis in China. |
| |
| Keywords: | Tuberculosis Immunologic techniques Protective agents Diagnosis Therapeutic uses |
|
| 点击此处可从《中国防痨通讯》浏览原始摘要信息 |
| 点击此处可从《中国防痨通讯》下载免费的PDF全文 |
|
